Palatin Technologies Inc. (PTN)

[mikedeatworld]

I will preface this by saying, I'm not the biggest Spana because of the warrants.

However, he did get over 570M in deals for bremelanotide alone. They did what they had to do to push a drug through several Phase I-III studies.

Looking back yeah, those warrants created a massive float. However, I think once they get the LATAM, Europe, and Australia/New Zealand deals for Bremelanotide we'll see $4-$5 range easily. This company has a billion market cap written all over it, *if* going forward they play their cards right and don't tap the capital markets.

PL-3994/the rest of the pipeline will be costly. However, compare to bremelanotide each drug is "easier" to study with indications that are quantifiable and measurable, unlike HSDD. So hopefully the cash-on-hand the have will suffice until they hit other milestones or royalties kick in. I see no reason, this company shouldn't hit $4-$5 in 2-3 years.